Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Zentalis Pharmaceuticals
Company

Zentalis Pharmaceuticals

Tracked across 1 events · 6 articles · First seen Aug 13, 2026 · Last active Aug 14, 2026

Sentiment
10
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 10
Business
Zentalis Pharmaceuticals $80.5M Public Offering
Zentalis Pharmaceuticals, a clinical oncology company, announced the pricing of an underwritten public offering of 23 million shares of common stock at $3.50 per share, expecting gross proceeds of approximately $80.5 million. The offering is…
Impact: Zentalis is the issuer, raising approximately $80.5 million to fund its clinical programs. The offering provides necessary capital but dilutes existing shareholders.
Aug 13, 2026 · 6 articles
Key Actions (2)
100 Zentalis Pharmaceuticals priced public offeringZentalis Pharmaceuticals...
40 Zentalis Pharmaceuticals granted underwriter optionZentalis Pharmaceuticals...
ERGEN INTELLIGENCE
Track Zentalis Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.